Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder

Urology

Volumn 50, Issue 2, 1997, Pages 199-206

  Walther, McClellan M ^c   Delaney, Thomas F ^a   Smith, Paul D ^d   Friauf, Walter S ^d   Thomas, Gunter F ^d   Shawker, Tom H ^d   Vargas, M Perla ^d   Choyke, Peter L ^d   Linehan, W Marston ^d   Abraham, Edward H ^d   Okunieff, Paul G ^d   Glatstein, Eli ^b  

^a University Hospital   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTRALIPID; LIPOSYN; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER CONTRACTION; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTECTOMY; FEMALE; FIBROSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LASER; MALE; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; VESICOURETERAL REFLUX;

EID: 18144436025     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00211-2     Document Type: Article

References (39)

1. Kelly JF, and Snell ME: Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 115: 150-151, 1976.
2. Harty JI, Amin M, Wieman TJ, Tseng MT, Ackerman D, and Broghamer W: Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 141: 1341-1346, 1989.
3. Hisazumi H, Misaki T, and Miyoshi N: Photoradiation therapy of bladder tumors. J Urol 130: 685-687, 1983.
4. Hisazumi H, Miyoshi N, Naito K, and Misaki T: Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: a preliminary report. J Urol 131: 884-887, 1984.
5. Nseyo UO, Dougherty TJ, and Sullivan L: Photodynamic therapy in the management of resistant lower urinary tract carcinoma. Cancer 60: 3113-3119, 1987.
6. Jocham D, Beer M, Baumgartner R, Staehler G, and Unsold E: Long-term experience with integral photodynamic therapy of TIS bladder carcinoma. Ciba Found Symp 146: 198-208, 1989.
7. Tsuchiya A, Obara N, Miwa M, Ohi T, Kato H, and Hayata Y: Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer. J Urol 130: 79-82, 1983.
8. Benson RC Jr: Integral photoradiation therapy of multifocal bladder tumors. Eur Urol 12(suppl 1): 47-53, 1986.
9. Shumaker BP, and Hetzel FW: Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem Photobiol 46: 899-901, 1987.
10. Prout GR Jr, Lin CW, Benson R Jr, Nseyo UO, Daly JJ, Griffin PP, Kinsey J, Tian ME, Lao YH, Mian YZ, et al: Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N Engl J Med 317: 1251-1255, 1987.
11. Windahl T, and Lofgren LA: Two years' experience with photodynamic therapy of bladder carcinoma. Br J Urol 71: 187-191, 1993.
12. D'Hallewin MA, Baert L, Marijnissen JP, and Star WM: Whole bladder wall photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder. J Urol 148: 1152-1155, 1992.
13. D'Hallewin MA, and Baert L: Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology 45: 763-767, 1995.
14. Kriegmair M, Waidelich R, Baumgartner R, Lumper W, Ehsan A, and Hofstetter A: Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy? Urologe [A] 33: 276-280, 1994.
15. Nseyo UO: Photodynamic therapy. Urol Clin North Am 19: 591-599, 1992.
16. Hisazumi H, Naito K, Uchibayashi T, Hirata A, and Komatsu K: Integral photodynamic therapy of superficial bladder tumors with special reference to carcinoma in situ. Scand J Urol Nephrol 138(suppl): 161-165, 1991.
17. Naito K, Hisazumi H, Uchibayashi T, Amano T, Hirata A, Komatsu K, Ishida T, and Miyoshi N: Integral laser photodynamic treatment of refractory multifocal bladder tumors. J Urol 146: 1541-1545, 1991.
18. Cai WM: Result and indication of photodynamic therapy in the treatment of malignant tumors - analysis of 165 patients. Chung Hua Chung Liu Tsa Chih 12: 69-71, 1990.
19. Tian ME: Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder - report of 30 cases. Chung Hua Chung Liu Tsa Chih 11: 304-306, 1989.
20. Javadpour N: Photodynamic therapy Tis and T1 transitional carcinoma of the bladder. Prog Clin Biol Res 303: 471-478, 1989.
21. Kriegmair M, Waidelich R, Lumper W, Ehsan A, Baumgartner R, and Hofstetter A: Integral photodynamic treatment of refractory superficial bladder cancer. J Urol 154: 1339-1341, 1995.
22. Freitas I: Role of hypoxia in photodynamic therapy of tumors. Tumori 71: 251-259, 1985.
23. Delaney TF, and Glatstein E: Photodynamic therapy of cancer. Compr Ther 14: 43-55, 1988.
24. Pass HI: Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 85: 443-456, 1993.
25. Weishaupt KR, Gomer CJ, and Dougherty TJ: Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36: 2326-2329, 1976.
26. Mitchell JB, McPherson S, DeGraff W, Gamson J, Zabell A, and Russo A: Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells. Cancer Res 45: 2008-2011, 1985.
27. Reed MW, Schuschke DA, Ackermann DM, Harty JI, Wieman TJ, and Miller FN: The response of the rat urinary bladder microcirculation to photodynamic therapy. J Urol 142: 865-868, 1989.
28. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, and Hawkins IR: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983.
29. Jakse G, Loidl W, Seeber G, and Hofstadter F: Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tomorrow? J Urol 137: 39-43, 1987.
30. Manyak MJ, Harrington FS, and Glatstein E: A flexible cystoscope holder/surgical retractor that really works. J Urol 138: 105-106, 1987.
31. Baghdassarian R, Wright MW, Vaughn SA, Berns MW, Martin DC, and Wile AG: The use of lipid emulsion as an intravesical medium to disperse light in the potential treatment of bladder tumors. J Urol 133: 126-130, 1985.
32. Star WM, Marijnissen HP, Jansen H, Keijzer M, and van Gemert MJ: Light dosimetry for photodynamic therapy by whole bladder wall irradiation. Photochem Photobiol 46: 619-624, 1987.
33. Manyak MJ, Smith PD, Harrington FS, Steinberg SM, Glatstein E, and Russo A: Protection against dihematoporphyrin ether photosensitivity. Photochem Photobiol 47: 823-830, 1988.
34. Shumaker BP, Lutz MD, Haas GP, and Hetzel F: Practical clinical use of laser photodynamic therapy in the treatment of bladder carcinoma in situ. Lasers Med Sci 1: 257-261, 1986.
35. Walther MM, Eanes ED, Delaney TF, and Travis WD: Bladder calcifications after photodynamic therapy. Analysis of a rare complication. Urology 47: 831-835, 1996.
36. van Staveren HJ, Keijzer M, Keesmaat T, Jansen H, Kirkel WJ, Beek JF, and Star WM: Integrating sphere effect in whole-bladder wall photodynamic therapy: III. Fluence multiplication, optical penetration and light distribution with an eccentric source for human bladder optical properties. Phys Med Biol 41: 579-590, 1996.
37. Perry RR, Evans S, Matthews W, Rizzoni W, Russo A, and Pass HI: Potentiation of phototherapy cytotoxicity with light scattering media. J Surg Res 46: 386-390, 1989.
38. Tochner Z, Mitchell JB, Harrington FS, Smith P, Russo DT, and Russo A: Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light. Cancer Res 45: 2983-2987, 1985.
39. Tochner Z, Mitchell JB, Smith P, Harrington F, Glatstein E, Russo D, and Russo A: Photodynamic therapy of ascites tumours within the peritoneal cavity. Br J Cancer 53: 733-736, 1986.